Association of dry eye and inflammatory systemic diseases in a tertiary care-based sample

Cornea

Volumn 33, Issue 8, 2014, Pages 819-825

  Henrich, Claudia F ^a   Ramulu, Pradeep Y ^a   Akpek, Esen K ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

dry eye; inflammatory systemic disease; Sj gren syndrome; thyroid eye disease

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CHEMOSIS; CLINICAL FEATURE; DISEASE ASSOCIATION; DRY EYE; ENDOCRINE OPHTHALMOPATHY; FAMILY HISTORY; FEMALE; HUMAN; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SJOEGREN SYNDROME; TERTIARY HEALTH CARE; ADOLESCENT; AGED; ARTHRITIS, RHEUMATOID; DRY EYE SYNDROMES; FIBROMYALGIA; GRAFT VS HOST DISEASE; LACRIMAL FLUID; MIDDLE AGED; PHYSIOLOGY; PREVALENCE; RETROSPECTIVE STUDY; SJOGREN'S SYNDROME; THYROID DISEASES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; DRY EYE SYNDROMES; FEMALE; FIBROMYALGIA; GRAFT VS HOST DISEASE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; SJOGREN'S SYNDROME; TEARS; TERTIARY HEALTHCARE; THYROID DISEASES; YOUNG ADULT;

EID: 84904245458     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0000000000000173     Document Type: Article

References (33)

1. Moss SE, Klein R, Klein BE. Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol. 2000;118:1264-1268
2. Chia EM, Mitchell P, Rochtchina E, et al. Prevalence and associations of dry eye syndrome in an older population: The Blue Mountains Eye Study. Clin Experiment Ophthalmol. 2003;31:229-232. (Pubitemid 36833372
3. Zlatanovic G, Veselinovic D, Cekic S, et al. Ocular manifestation of rheumatoid arthritis-different forms and frequency. Bosn J Basic Med Sci. 2010;10:323-327
4. Türkyilmaz K, Türkyilmaz AK, Kurt EE, et al. Dry eye in patients with fibromyalgia and its relevance to functional and emotional status. Cornea. 2013;32:862-866
5. Bonafede RP, Downey DC, Bennett RM. An association of fibromyalgia with primary Sjögren's syndrome: A prospective study of 72 patients. J Rheumatol. 1995;22:133-136
6. Davies JB, Rao PK. Ocular manifestations of systemic lupus erythematosus. Curr Opin Ophthalmol. 2008;19:512-518
7. Lima FB, Abalem MF, Ruiz DG, et al. Prevalence of eye disease in Brazilian patients with psoriatic arthritis. Clinics (Sao Paulo). 2012;67: 249-253
8. Gumus K, Yurci A, Mirza E, et al. Evaluation of ocular surface damage and dry eye status in chronic hepatitis C at different stages of hepatic fibrosis. Cornea. 2009;28:997-1002
9. Liew MS, Zhang M, Kim E, et al. Prevalence and predictors of Sjogren's syndrome in a prospective cohort of patients with aqueous-deficient dry eye. Br J Ophthalmol. 2012;96:1498-1503
10. Akpek EK, Klimava A, Thorne JE, et al. Evaluation of patients with dry eye for presence of underlying Sjogren syndrome. Cornea. 2009;28:493-497
11. Gupta A, Sadeghi PB, Akpek EK. Occult thyroid eye disease in patients presenting with dry eye symptoms. Am J Ophthalmol. 2009;147:919-923
12. Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22:640-650. (Pubitemid 37175145
13. Byrne SF, Gendron EK, Glaser JS, et al. Diameter of normal extraocular recti muscles with echography. Am J Ophthalmol. 1991;112:706-713
14. Scott IU, Siatkowski MR. Thyroid eye disease. Semin Ophthalmol. 1999; 14:52-61. (Pubitemid 29307698
15. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: A revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61: 554-558. (Pubitemid 34539104
16. Greenspan JS, Daniels TE, Talal N, et al. The histopathology of Sjögren's syndrome in labial salivary gland biopsies. Oral Surg Oral Med Oral Pathol. 1974;37:217-229
17. Lemp MA, Crews LA, Bron AJ, et al. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: A retrospective study. Cornea. 2012;31:472-478
18. Barisani-Asenbauer T, Maca SM, Mejdoubi L, et al. Uveitis-A rare disease often associated with systemic diseases and infections-A systematic review of 2619 patients. Orphanet J Rare Dis. 2012;7:57. Available at: Http://www.ojrd.com/content/7/1/57. Accessed October 20, 2013
19. Rothova A, Buitenhuis HJ, Meenken C, et al. Uveitis and systemic disease. Br J Ophthalmol. 1992;76:137-141
20. Jakob E, Reuland MS, Mackensen F, et al. Uveitis subtypes in a German interdisciplinary uveitis center-Analysis of 1916 patients. J Rheumatol. 2009;36:127-136
21. Akpek EK, Thorne JE, Qazi FA, et al. Evaluation of patients with scleritis for systemic disease. Ophthalmology. 2004;111:501-506. (Pubitemid 38293106
22. Kruszka P, O'Brian RJ. Diagnosis and management of Sjögren syndrome. Am Fam Physician. 2009;79:465-470
23. Baldini C, Pepe P, Luciano N, et al. A clinical prediction rule for lymphoma development in primary Sjögren's syndrome. J Rheumatol. 2012; 39:804-808
24. Voulgarelis M, Skopouli FN. Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients. Clin Rev Allergy Immunol. 2007;32:265-274. (Pubitemid 350242572
25. Harley JB, Alexander EL, BiasWB, et al. Anti-ro (SS-A) and anti-la (SS-B) in patients with Sjögren's syndrome. Arthritis Rheum. 1986;29:196-206. (Pubitemid 17022820
26. Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A, et al. Topical and systemic medications for the treatment of primary Sjögren's syndrome. Nat Rev Rheumatol. 2012;8:399-411
27. Fox RI, Chan E, Benton L, et al. Treatment of primary Sjogren's syndrome with hydroxychloroquine. Am J Med. 1988;85:62-67
28. Bowman S, Barone F. Biologic treatments in Sjogren's syndrome. Presse Med. 2012;41:e495-509. Available at: Http://www.em-consulte.com/ article/749274/alertePM. Accessed October 20, 2013
29. Gottenberg JE, Cinquetti G, Larroche C, et al. Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: Results in 78 patients of the AutoImmune and Rituximab registry. Ann Rheum Dis. 2013;72:1026-1031
30. Douglas RS, Gupta S. The pathophysiology of thyroid eye disease: Implications for immunotherapy. Curr Opin Ophthalmol. 2011;22: 385-390
31. Jara LJ, Navarro C, Brito-Zerón Mdel P, et al. Thyroid disease in Sjögren's syndrome. Clin Rheumatol. 2007;26:1601-1606
32. Ramos-Casals M, García-Carrasco M, Cervera R, et al. Thyroid disease in primary Sjogren syndrome. Study in a series of 160 patients. Medicine (Baltimore). 2000;79:103-108
33. Zeher M, Horvath IF, Szanto A, et al. Autoimmune thyroid diseases in a large group of Hungarian patients with primary Sjögren's syndrome. Thyroid. 2009;19:39-45